President and Chief Executive Officer
John Higgins is President, Chief Executive Officer and a member of the Board of Directors of Ligand Pharmaceuticals.
Prior to joining Ligand, Mr Higgins served as Chief Financial Officer and Executive Vice President, Finance and Administration and Corporate Development, of Connetics Corporation, a specialty pharmaceutical company acquired by Stiefel Laboratories in 2006.
Before joining Connetics, he was a member of the executive management team at BioCryst Pharmaceuticals. Currently, he is a Director on the Boards of Techne Corporation, CoMentis and BioCryst and serves as Chairperson of the Techne Audit Committee. Prior to BioCryst, Mr Higgins was a member of the healthcare banking team of Dillon, Read & Co. Inc., an investment banking firm.
He graduated Magna Cum Laude from Colgate University with an AB in economics.